Kingson Lin

Kingson Lin is the Co-Founder of Modifi Bio and a Consultant. With a background in biochemistry and organic chemistry, Kingson has conducted research in organic methodologies and designed therapeutic agents for brain cancer during their time at Yale University School of Medicine and the University of Pennsylvania. Kingson holds a Bachelor's degree in Biochemistry, a Master's degree in Organic Chemistry, and is pursuing a Doctor of Medicine and Doctor of Philosophy in Pathology/Experimental Pathology.